Bioqual Profit Margin 2010-2024 | BIOQ

Current and historical gross margin, operating margin and net profit margin for Bioqual (BIOQ) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bioqual net profit margin as of November 30, 2024 is -5.54%.
Bioqual Annual Profit Margins
Bioqual Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.054B $0.059B
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.312B 0.00
Quest Diagnostics (DGX) United States $18.153B 18.23
DaVita (DVA) United States $14.110B 18.25
Encompass Health (EHC) United States $9.934B 22.26
Chemed (CHE) United States $8.335B 25.62
Elanco Animal Health (ELAN) United States $5.917B 14.08
Option Care Health (OPCH) United States $5.245B 24.85
RadNet (RDNT) United States $4.764B 105.51
LifeStance Health (LFST) United States $3.053B 0.00
Amedisys (AMED) United States $3.017B 21.47
Addus HomeCare (ADUS) United States $2.171B 25.48
Astrana Health (ASTH) United States $2.001B 27.37
U.S Physical Therapy (USPH) United States $1.324B 34.81
Aveanna Healthcare Holdings (AVAH) United States $0.935B 0.00
Pennant (PNTG) United States $0.935B 37.81
Atai Life Sciences (ATAI) Germany $0.356B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00